Clínica Universidad de Navarra (CUN)
Centro clínico de la Universidad de Navarra
Stanford University
Stanford, Estados UnidosPublicacions en col·laboració amb investigadors/es de Stanford University (36)
2024
-
A road map for the treatment of pediatric diffuse midline glioma
Cancer Cell
-
Multidisciplinary Delphi Consensus on Safety of Combining Transarterial Radioembolization with Yttrium-90 Microspheres with Systemic Anticancer Agents for the Treatment of Liver Malignancy
Journal of Vascular and Interventional Radiology, Vol. 35, Núm. 9, pp. 1253-1267.e1
-
Patient care and access to clinical trials in gynaecological oncology: global implications of the early phase of the COVID-19 pandemic
Archives of Gynecology and Obstetrics, Vol. 310, Núm. 1, pp. 577-586
-
Stroke in critically ill patients with respiratory failure due to COVID-19: Disparities between low-middle and high-income countries
Heart and Lung, Vol. 68, pp. 131-144
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Advanced MR Techniques for Preoperative Glioma Characterization: Part 1
Journal of Magnetic Resonance Imaging, Vol. 57, Núm. 6, pp. 1655-1675
-
Advanced MR Techniques for Preoperative Glioma Characterization: Part 2
Journal of Magnetic Resonance Imaging, Vol. 57, Núm. 6, pp. 1676-1695
-
Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)
Leukemia
-
Defining textbook outcome for selective internal radiation therapy of hepatocellular carcinoma: an international expert study
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 50, Núm. 3, pp. 921-928
-
Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical Validation
Cancers, Vol. 15, Núm. 13
-
Identifying key multifunctional components shared by critical cancer and normal liver pathways via SparseGMM
Cell Reports Methods, Vol. 3, Núm. 1
2022
-
Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis
Critical Care, Vol. 26, Núm. 1
-
Quality-adjusted time without symptoms of disease or toxicity and quality-adjusted progression-free survival with niraparib maintenance in first-line ovarian cancer in the PRIMA trial
Therapeutic Advances in Medical Oncology, Vol. 14
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials
Leukemia, Vol. 35, Núm. 1, pp. 18-30
-
Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer
JAMA Network Open, Vol. 4, Núm. 12, pp. E2138550
-
Pressure injury prediction models for critically-ill patients should consider both the case-mix and local factors
Intensive and Critical Care Nursing
-
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
The Lancet Oncology, Vol. 22, Núm. 3, pp. e105-e118
2020
-
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, Núm. 8, pp. 1885-1912
2018
-
Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials
JAMA Ophthalmology, Vol. 136, Núm. 6, pp. 666-677